 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy Edwards Lifesciences stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:EW! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Edwards Lifesciences stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient’s heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient’s physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Average volume
2.71 million shs
MARKET CAP
$53.67 billion
Stock exchange
NYSE
Buy this stock!
|
NAME
|
TICKER
|
INDUSTRY
|
SECTOR
|
VOLUME
|
BUY THIS STOCK NOW
|
|---|---|---|---|---|---|
|
NYSE:EW
|
Surgical appliances & supplies
|
Medical
|
33,442 shs
|
Below is a quick guide on how to buy NYSE:EW stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Edwards Lifesciences shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Edwards Lifesciences – Search for “”NYSE:EW”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Edwards Lifesciences stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
20 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Edwards Lifesciences in the last year. There are currently 2 sell ratings, 6 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Edwards Lifesciences stock.
Wall Street analysts have given Edwards Lifesciences a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Edwards Lifesciences wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:EW stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Edwards Lifesciences stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Edwards Lifesciences stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Now that you’ve funded your eToro account, just type “NYSE:EW stocks” into the search bar at the top of the screen and press “trade”.
All that’s left is to buy some NYSE:EW stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:EW is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Edwards Lifesciences stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Edwards Lifesciences is scheduled to release its next quarterly earnings announcement on Thursday, April 22nd 2021.
View our earnings forecast for Edwards Lifesciences.
Edwards Lifesciences Co. (NYSE:EW) announced its quarterly earnings data on Tuesday, January, 26th. The medical research company reported $0.50 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.53 by $0.03. The medical research company had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.18 billion. Edwards Lifesciences had a trailing twelve-month return on equity of 29.00% and a net margin of 18.18%. The firm’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.46 EPS.
View Edwards Lifesciences’ earnings history.
Edwards Lifesciences’ stock was trading at $65.79 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EW stock has increased by 30.7% and is now trading at $86.00.
Edwards Lifesciences shares split before market open on Friday, May 29th 2020. The 3-1 split was announced on Thursday, May 7th 2020. The newly created shares were payable to shareholders after the market closes on Monday, May 18th 2020. An investor that had 100 shares of Edwards Lifesciences stock prior to the split would have 300 shares after the split.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:EW stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Edwards Lifesciences updated its FY21 earnings guidance on Wednesday, January, 27th. The company provided EPS guidance of $2.00-2.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.13. The company issued revenue guidance of $4.90-5.30 billion, compared to the consensus revenue estimate of $5.10 billion.
20 brokers have issued 12-month target prices for Edwards Lifesciences’ stock. Their forecasts range from $51.67 to $111.00. On average, they expect Edwards Lifesciences’ share price to reach $91.12 in the next year. This suggests a possible upside of 6.0% from the stock’s current price.
View analysts’ price targets for Edwards Lifesciences or view top-rated stocks among Wall Street analysts.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Edwards Lifesciences’ management team includes the following people:
Mr. Michael A. Mussallem, Chairman & CEO (Age 68, Pay $3.64M)
Mr. Scott B. Ullem, Corp. VP & CFO (Age 54, Pay $1.42M)
Mr. Donald E. Bobo Jr., Corp. VP of Strategy & Corp. Devel. (Age 59, Pay $1.36M)
Mr. Larry L. Wood, Corp. VP of Transcatheter Aortic Valve Replacement (Age 55, Pay $1.46M)
Mr. Jean-Luc Lemercier, Corp. VP of Europe, Middle East, Africa, Canada & Latin America (Age 64, Pay $1.33M)
Dr. Todd J. Brinton, Corp. VP of Advanced Technology & Chief Scientific Officer
Mark Wilterding, VP of Investor Relations
Mr. Arnold A. Pinkston, Corp. VP & Gen. Counsel (Age 62)
Mr. Dirksen J. Lehman, Corp. VP of Public Affairs
Ms. Christine Z. McCauley, Corp. VP of HR (Age 56)
389 employees have rated Edwards Lifesciences CEO Michael A. Mussallem on Glassdoor.com. Michael A. Mussallem has an approval rating of 90% among Edwards Lifesciences’ employees.
Some companies that are related to Edwards Lifesciences include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD), Varian Medical Systems (VAR) and STERIS (STE).
View all of EW’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Edwards Lifesciences investors own include NVIDIA (NVDA), Alibaba Group (BABA), The Home Depot (HD), salesforce.com (CRM), The Walt Disney (DIS), Visa (V), Johnson & Johnson (JNJ), QUALCOMM (QCOM), Micron Technology (MU) and CVS Health (CVS).
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Edwards Lifesciences trades on the New York Stock Exchange (NYSE) under the ticker symbol “EW.”
Edwards Lifesciences’ stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.40%), FMR LLC (1.41%), Fisher Asset Management LLC (0.90%), Sumitomo Mitsui Trust Holdings Inc. (0.60%), Jennison Associates LLC (0.42%) and Swiss National Bank (0.38%). Company insiders that own Edwards Lifesciences stock include Catherine M Szyman, Donald E Bobo Jr, Huimin Wang, Jean-Luc M Lemercier, Larry L Wood, Michael A Mussallem, Nicholas J Valeriani, Robert WA Sellers, Schack Wesley W Von, Scott B Ullem and William J Phd Link.
View institutional ownership trends for Edwards Lifesciences.
EW stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Jennison Associates LLC, BlackRock Inc., Frontier Capital Management Co. LLC, NorthCoast Asset Management LLC, Robeco Institutional Asset Management B.V., Swiss National Bank, and California Public Employees Retirement System. Company insiders that have sold Edwards Lifesciences company stock in the last year include Catherine M Szyman, Donald E Bobo Jr, Huimin Wang, Jean-Luc M Lemercier, Larry L Wood, Michael A Mussallem, Nicholas J Valeriani, Robert WA Sellers, and Scott B Ullem.
View insider buying and selling activity for Edwards Lifesciences or view top insider-selling stocks.
EW stock was acquired by a variety of institutional investors in the last quarter, including Royal London Asset Management Ltd., Ardevora Asset Management LLP, Fisher Asset Management LLC, Retirement Systems of Alabama, Russell Investments Group Ltd., UMB Bank N A MO, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA, and PGGM Investments.
View insider buying and selling activity for Edwards Lifesciences or or view top insider-buying stocks.
Shares of EW can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, DEGiro Review, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review and many more. Read one of the reviews to find out everything about the broker and start buying stocks now.
One share of EW stock can currently be purchased for approximately $86.00.
At Reportlab.org we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
How to buy Edwards Lifesciences stocks?
The safest and easiest way to buy NYSE:EW stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Opening an account with one of these brokers is a smart move, they have been active for more then 10 years, are very safe to use and they have the best platform for novice and experienced traders. If you want to learn more then we suggest you to read our eToro or DeGiro guides.
Where to buy Edwards Lifesciences stock?
You will first want to find a licensed broker that supports Edwards Lifesciences stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:EW stocks in a safe and complete environment.
Is NYSE:EW stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:EW stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Edwards Lifesciences stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:EW is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Edwards Lifesciences stock.
How do you trade Edwards Lifesciences stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Edwards Lifesciences stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:EW stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Edwards Lifesciences stock?
To sell your NYSE:EW stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Edwards Lifesciences stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:EW stock.
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
| |
Our score |
0% commission |
Realtime Stocks & Crypto data
Notifications, Tips & News
Best Stocks & Crypto Guides
Online Broker & Exchange Reviews
Reportlab Finance is purely an informative website and in no case implies investment advice. All investments carry risks and you can lose all your investments. Do not invest money that you cannot afford to lose.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
United Kingdom
Copyright © 2022 Reportlab.Finance | All rights reserved.
